Image positional


SimvaStatin in Neurofibromatosis Type 1- Autism is a research study looking at the use of the drug Simvastatin in children with NF1 and Autism Spectrum Disorders (ASD).

This is a phase II exploratory study of statin treatment in young children aged 5-8 years with NF1 and autism. The purpose of this study is to test acceptability and feasibility of involvement for families and the feasibility of imaging young children with NF1 autism.